Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: Indirect evaluation of sensitivity to GH

European Journal of Endocrinology

Volumn 144, Issue 3, 2001, Pages 251-256

  Maccario, M ^a   Tassone, F ^a   Gauna, C ^a   Oleandri, S E ^a   Aimaretti, G ^a   Procopio, M ^a   Grottoli, S ^a   Pflaum, C D ^a   Strasburger, C J ^a   Ghigo, E ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE BINDING PROTEIN; HYDROCORTISONE; INSULIN; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CUSHING SYNDROME; FEMALE; GLUCOSE BLOOD LEVEL; HIP; HORMONE SENSITIVITY; HUMAN; HYPERCORTISOLISM; HYPERINSULINISM; HYPOTHESIS; INSULIN BLOOD LEVEL; OBESITY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0035062396     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1440251     Document Type: Article

References (37)

1. Nutritional regulation of the insulin-like growth factors
2. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion
3. Insulin and growth hormone act synergistically to stimulate insulin-like growth factor-I production by cultured chicken hepatocytes
4. Somatomedin production by rat liver in organ culture. III. Studies on the release of insulin-like growth factor and its carrier protein measured by radioligand assays. Effects of growth hormone, insulin and cortisol
5. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic-stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers
6. The evolution of changes in immunoreactive serum insulin-like growth factors (IGFs), IGF-binding proteins, circulating growth hormone (GH) and GH-binding protein as a result of short-term dexamethasone treatment
7. Basic counterpoint: Mechanisms and pathways of gonadal steroid modulation of growth hormone secretion
8. Cortisol decreases IGF-I mRNA levels in human osteoblast-like cells
9. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man
10. Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure
11. Relations between immunoreactive somatomedin C, insulin and T3 patterns during fasting in obese subjects
12. The relationship between insulin-like growth factor-I, adiposity, and aging
13. Relationship between plasma insulin-like growth factor I (IGF-I) levels and body mass index (BMI) in adults
14. Growth hormone axis in Cushing's syndrome
15. Insulin-like growth factor (IGF) I and II IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome
16. Free insulin-like growth factors in human obesity
17. Low concentrations of insulin-like growth factor-I in abdominal obesity
18. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution
19. Circulating growth hormone binding proteins
20. Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women
21. Ligand-mediated immunofunctional assay for quantitation of growth hormone-binding protein in human blood
22. A non isotopic solid phase immunoassay for the determination of growth hormone binding protein (hGHBP)
23. Activation of chimeric and full-length growth hormone receptors by growth hormone receptor monoclonal antibodies. A specific conformational change may be required for full-length receptor signaling
24. Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity
25. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome
26. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary restriction in patients with Cushing's syndrome
27. The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa
28. Serum growth hormone-binding protein in obesity: Effect of a short-term, very low calorie diet and diet-induced weight loss
29. Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity
30. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
31. Dexamethasone induces an acute and sustained rise in circulating leptin levels in normal human subjects
32. Regulation of growth hormone secretion by signals produced by the adipose tissue
33. Clinical aspects of growth hormone deficiency in adults
34. Effects of growth hormone on glucose metabolism
35. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure
36. Insulin secretion in growth hormone-deficient adults: Effects of 24 months' therapy and five days' acute withdrawal of recombinant human growth hormone